최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of cardiology, v.71 no.1, 2018년, pp.36 - 43
Park, Keun-Ho (Chosun University Hospital, Gwangju, Republic of Korea) , Jeong, Myung Ho (Chonnam National University Hospital, Gwangju, Republic of Korea) , Kim, Hyun Kuk (Chosun University Hospital, Gwangju, Republic of Korea) , Ahn, Tae Hoon (Gachon University Gil Medical Center, Incheon, Republic of Korea) , Seung, Ki Bae (The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, Republic of Korea) , Oh, Dong Joo (Korea University Guro Hospital, Seoul, Republic of Korea) , Choi, Dong-Joo (Seoul National University Bundang Hospital, Seoul, Republic of Korea) , Kim, Hyo-Soo (Seoul National University Hospital, Seoul, Republic of Korea) , Gwon, Hyeon Cheol (Sungkyunkwan University Samsung Medical Center, Seoul, Republic of Korea) , Seong, In Whan (Chungnam National University Hospital, Daejeon, Republic of Korea) , Hwang, Kyung Kuk (Chungbuk National University Hospital, Cheongju, Republic of Korea) , Chae, Shung Chull (Kyungpook National University Hospital, Daegu, Republic of Korea) , Kim, Kwon-Bae (Keimyung University Dongsan Medical Center, Daegu, Republic of Korea) , Kim, Young Jo (Yeungnam University Hospital, Daegu, Republic of Korea) , Cha, Kwang Soo (Pusan National University Hospital, Busan, Republic of Korea) , Oh, Seok Kyu (Wo) , Chae, Jei Keon
Conclusions: Our study shows that the recommended dose of prasugrel had significantly higher in hospital bleeding complications without reducing ischemic events compared with clopidogrel. However, further large-scale, long-term, randomized clinical trials are required to accurately assess the effica...
N Engl J Med Leon 339 1665 1998 10.1056/NEJM199812033392303 A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators
N Engl J Med Yusuf 345 494 2001 10.1056/NEJMoa010746 Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial I. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
Heart Clappers 93 258 2007 10.1136/hrt.2005.071209 Antiplatelet treatment for coronary heart disease
JAMA Eagle 291 2727 2004 10.1001/jama.291.22.2727 A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry
JAMA Steg 297 1197 2007 10.1001/jama.297.11.1197 One-year cardiovascular event rates in outpatients with atherothrombosis
Eur Heart J Roffi 37 267 2016 10.1093/eurheartj/ehv320
Circulation Levine 134 e123 2016 10.1161/CIR.0000000000000404
Cardiovasc Drug Rev Jakubowski 25 357 2007 10.1111/j.1527-3466.2007.00027.x Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile
J Cardiol Park 63 99 2014 10.1016/j.jjcc.2013.07.004 Comparison of peri-procedural platelet inhibition with prasugrel versus adjunctive cilostazol to dual anti-platelet therapy in patients with ST segment elevation myocardial infarction
J Cardiol Kubo 69 436 2017 10.1016/j.jjcc.2016.04.005 Reduction of in-stent thrombus immediately after percutaneous coronary intervention by pretreatment with prasugrel compared with clopidogrel: an optical coherence tomography study
Am J Cardiol Wiviott 108 905 2011 10.1016/j.amjcard.2011.05.020 Efficacy and safety of intensive antiplatelet therapy with prasugrel from TRITON-TIMI 38 in a core clinical cohort defined by worldwide regulatory agencies
Circ J Kim 80 1427 2016 10.1253/circj.CJ-16-0061 Multicenter cohort study of acute myocardial infarction in Korea-interim analysis of the Korea Acute Myocardial Infarction Registry-National Institutes of Health Registry
Circulation Mehran 123 2736 2011 10.1161/CIRCULATIONAHA.110.009449 Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium
Multivariate Behav Res Austin 46 399 2011 10.1080/00273171.2011.568786 An introduction to propensity score methods for reducing the effects of confounding in observational studies
Eur Heart J Patrono 32 2922 2011 10.1093/eurheartj/ehr373 Antiplatelet agents for the treatment and prevention of atherothrombosis
Nat Rev Cardiol Levine 11 597 2014 10.1038/nrcardio.2014.104 Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI
J Am Coll Cardiol Shen 50 309 2007 10.1016/j.jacc.2007.01.098 Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation
Thromb Haemost Ma 107 1014 2012 10.1160/TH11-04-0214 Current antithrombotic treatment in East Asia: some perspectives on anticoagulation and antiplatelet therapy
Circ J Goto 79 2452 2015 10.1253/circj.CJ-15-0112 Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome - randomized, double-blind, phase III PHILO study
Int J Cardiol Park 215 193 2016 10.1016/j.ijcard.2016.04.044 Comparison of short-term clinical outcomes between ticagrelor versus clopidogrel in patients with acute myocardial infarction undergoing successful revascularization; from Korea Acute Myocardial Infarction Registry-National Institute of Health
J Am Coll Cardiol O’Donoghue 54 678 2009 10.1016/j.jacc.2009.05.025
Circ J Saito 78 1684 2014 10.1253/circj.CJ-13-1482 Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study
Circ J Saito 79 1928 2015 10.1253/circj.CJ-15-0276 Impact of arterial access route on bleeding complications in Japanese patients undergoing percutaneous coronary intervention - insight from the PRASFIT Trial
J Am Coll Cardiol Doyle 53 2019 2009 10.1016/j.jacc.2008.12.073 Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice
Circ Cardiovasc Interv Iqbal 7 456 2014 10.1161/CIRCINTERVENTIONS.114.001314 Radial versus femoral access is associated with reduced complications and mortality in patients with non-ST-segment-elevation myocardial infarction: an observational cohort study of 10,095 patients
Lancet Valgimigli 385 2465 2015 10.1016/S0140-6736(15)60292-6 Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
J Cardiol Numasawa 69 272 2017 10.1016/j.jjcc.2016.05.003 Incidence and predictors of bleeding complications after percutaneous coronary intervention
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.